| 41 |
The diagnostic efficacy of tailored multiparametric breast MRI in indeterminate mammographic lesions: a single tertiary oncology center |
2020 |
| 42 |
The role of circulating tumor cells as a prognostic marker in the adjuvant setting of patients with breast cancer |
2020 |
| 43 |
Circulating tumor cells as a prognostic marker in non-metastatic breast cancer patients |
2018 |
| 44 |
Concurrent nivolumab and radiotherapy to improve outcomes for patients with metastatic lung and renal cancers. |
2018 |
| 45 |
Multiple Primary Malignancies: Metastatic Renal with Early Breast and Endometrial Cancers: A Case Report |
2018 |
| 46 |
Platinum and Taxane-Induced Neuropathy and Its Impact on Quality of Life: A Single Institution Study |
2018 |
| 47 |
Rare Case of Intracardiac Renal Cell Carcinoma Metastasis with Response to Nivolumab: Case Report and Literature Review |
2018 |
| 48 |
Prognostic Factors in Advanced Non-Small Cell Lung Cancer and Their Relation to Clinical Outcomes |
2017 |
| 49 |
Incidence of brain metastases in HER-2 positive (early and metastatic) breast cancer patients treated with trastuzumab—The Sultanate of Oman experience 2002–2007 |
2008 |
| 50 |
Evaluation of the prevalence, pattern and management of cancer pain in Oncology Department, The Royal Hospital, Oman |
2007 |